Advertisement
Advertisement

RPRX

RPRX logo

Royalty Pharma plc Class A Ordinary Shares

50.79
USD
Sponsored
+0.59
+1.18%
May 08, 15:59 UTC -4
Closed
exchange

After-Market

50.52

-0.27
-0.52%

Royalty Pharma plc Class A Ordinary Shares Profile

About

Royalty Pharma plc is a funder of biopharmaceutical industry. The compnay's portfolio includes royalties on commercial products, including AbbVie and J&J's Imbruvica, Astellas and Pfizer's Xtandi, Biogen's Tysabri, Gilead's HIV franchise, Merck's Januvia, Novartis' Promacta and Vertex's Kalydeco, Symdeko and Trikafta, and development-stage product candidates. Royalty Pharma plc is based in NEW YORK.

Info & Links

CEO

Pablo Legorreta

Headquarters

110 East 59th Street
New York, NY 10022, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.royaltypharma.com

Auditor

Ernst & Young LLP

Share holders

7

Employees

100

Royalty Pharma plc Class A Ordinary Shares Statistics

Valuation Measures

Market Capitalization2

22.40B

Enterprise Value

30.77B

Enterprise Value/EBITDA(ttm)

18.94

Price to Earnings Ratio(ttm)

10.00

Price to Sales(ttm)

11.72

Price to Book(mrq)

2.87

Price to Cash(ytd)

10.11

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

114.55%

Profit Margin(ttm)

32.23%

Return on Equity(ttm)

28.21%

Return on Invested Capital(ttm)

7.58%

Return on Assets(ttm)

14.55%

Income Statement

Revenue(ttm)

2.44B

Revenue Per Share(ttm)

4.24

Gross Profit(ttm)

2.44B

EBITDA(ttm)3

1.62B

Net Income Available to Common(ttm)

826.29M

Diluted EPS(ttm)

1.35

Share Statistics

Beta (5Y Monthly)

0.39

52-Week Change

53.44%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

575.83M

Dividend Yield

1.95%

Float4

467.83M

% Held by Insiders

18.90%

% Held by Institutions

54.35%

Balance Sheet

Total Cash(mrq)

608.29M

Total Cash Per Share(mrq)

1.06

Total Debt(mrq)

8.96B

Total Debt/Equity(mrq)

92.14%

Current Ratio(mrq)

2.40%

Quick Ratio(mrq)

2.40%

Book Value Per Share(mrq)

9.83

Cash Flow

Operating Cash Flow Per Share(ytd)

4.41

Free Cash Flow(ytd)

2.49B

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement